Hospital de Clinicas Jose de San Martin. Buenos Aires University
Buenos Aires, B1622, Argentina
NCT Number: NCT05452603
Gastroesophageal reflux disease (GERD) is extremely common in our environment. Its diagnosis is complex. The Lyon Consensus defined, based on 24-hour pH monitoring, that an acid exposure time greater than 6% is definitely abnormal, less than 4% is normal, and between 4 and 6% is a gray area.
The objective of this study is to describe the change in therapeutic behavior based on the result of prolonged pH recording performed with a 96-hour wireless pH measurement capsule in patients with GERD symptoms and an acid exposure time measured by impedanciometry/pH of 24 hours in the gray area. Also, describe the therapeutic outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Buenos Aires, B1622, Argentina
Thirty consecutive patients with GERD symptoms and an acid exposure time (AET) measured by impedance measurement/pH between 4 and 6% will be included.
A 96-hour off IBP wireless pH monitoring capsule will be performed. The worst day, the average of the 4 days and the presence of 2 or more days with AET>6% and the 4 days with AET<4% will be recorded.
Patients will be categorized into GERD, reflux hypersensitivity, and functional heartburn. A treatment will be established based on these categories and the GERDq will be measured at 8 weeks of treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The endoscopic pH measurement capsule will be placed 6cm above the squamocolumnar junction, determined endoscopically, in the sedated patient. Then the plot will be read.
Time frame: june 2021-june 2023
estimate the proportion of GERD measured by wireless pH monitoring capsule in patients in the gray area
Time frame: june 2021-june 2023
To compare the GERDq scale before and after treatment with proton pump inhibitors.
Hospital de Clinicas José de San Martín
Other
Usefulness of Wireless pH Monitoring in the Diagnosis of Gastroesophageal Reflux Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05556824
Deglutition Disorders, Digestive System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03596411
Deglutition Disorders, Digestive System Diseases
Nice, Alpes Maritimes, France
View Trial DetailsNCT02083952
Apnea, Arrhythmias, Cardiac
Ridgewood, New Jersey, United States
View Trial DetailsNCT06329583
Deglutition Disorders, Digestive System Diseases
Jacksonville, Florida, United States
View Trial Details